Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of FPR2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Host species | Goat |
| Applications | ELISA |
More info about FPR2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB6895 |
| Product name: | FPR2 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of FPR2. |
| Gene id: | 2358 |
| Gene name: | FPR2 |
| Gene alias: | ALXR|FMLP-R-II|FMLPX|FPR2A|FPRH1|FPRH2|FPRL1|HM63|LXA4R |
| Gene description: | formyl peptide receptor 2 |
| Immunogen: | A synthetic peptide corresponding to amino acids 328-339 of human FPR2. |
| Immunogen sequence/protein sequence: | C-DSAPTNDTAANS |
| Protein accession: | NP_001005738.1;NP_001453.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:2000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Specificity: | Both reported variants (NP_001005738.1 and NP_001453.1) are identical proteins. |
| Applications: | ELISA |
| Shipping condition: | Dry Ice |
| Publications: | Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound.Vachier I, Bonnans C, Chavis C, Farce M, Godard P, Bousquet J, Chanez P. J Allergy Clin Immunol. 2005 Jan;115(1):55-60. |